Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01898299 · ClinicalTrials.gov registry record · NA
TDCS for Auditory Hallucinations in Schizophrenia
A NA study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT01898299 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 89 participants.
The verdict
NCT01898299, a NA study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
The purpose of the present research is to test a potential new treatment for auditory verbal hallucinations in schizophrenia that uses transcranial Direct Current Stimulation (tDCS), a neurostimulation technique that passes an extremely weak electric current through the brain. During the treatment, two electrodes are positioned on the scalp above regions of the brain implicated in abnormal cortical activity associated with auditory verbal hallucinations in schizophrenia. Due to the directional flow of current, one electrode, termed "cathodal",inhibits cortical activity, and the other, termed "anodal", increases cortical activity. These electrodes will be placed such that cathodal stimulation is applied to an area associated with hyperactivity and anodal stimulation to an area associated with hypoactivity. One preliminary study has revealed that this form of neurostimulation can alleviate auditory verbal hallucination symptoms both immediately following five days of treatment and up to three months after the final treatment. The goal of this study is to replicate these effects and explore the mechanisms that may underpin them.
Interventions
- DEVICE Sham tDCS
- DEVICE transcranial Direct Current Stimulation (tDCS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2013-05 |
| Est. Completion | 2018-08-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01898299
The ClinicalTrials.gov registry entry for NCT01898299 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham tDCS is the first listed.
NCT01898299 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01898299 about?
NCT01898299 is a clinical study titled "TDCS for Auditory Hallucinations in Schizophrenia". The purpose of the present research is to test a potential new treatment for auditory verbal hallucinations in schizophrenia that uses transcranial Direct Current Stimulation (tDCS), a neurostimulation technique that passes an extremely weak electric current through the brain. During the treatment, ...
What is the current status of trial NCT01898299?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2013-05. Estimated completion is 2018-08-14.
What interventions are being tested in trial NCT01898299?
The interventions under investigation include: Sham tDCS (DEVICE), transcranial Direct Current Stimulation (tDCS) (DEVICE).
Who is sponsoring clinical trial NCT01898299?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.